Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lugol's Solution Concentration for Esophageal Neoplasia Imaging
NCT03180970Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Jun 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Lugol's solution in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Shandong University. Status: unknown.
02
Drugs
Lugol's solution
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03180970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180970.